Insight Molecular Diagnostics Inc. (IMDX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.64M | -5.54M | -4.5M | -6.28M | -5.86M | -5.35M | -5.55M | -5.98M | -3.83M | -4.56M | -2.26M | -6.83M |
| Operating CF Margin % | -23871.88% | -486.83% | -1731.54% | -1212.16% | -273.99% | -360.3% | -4826.96% | -5748.08% | -2176.14% | -1452.87% | -526.57% | -1475.59% |
| Operating CF Growth % | -30.4% | -3.57% | 18.9% | -5.04% | -52.95% | -17.36% | -145.73% | 12.5% | 53.86% | 52.72% | 80.18% | 39.25% |
| Net Income | -4.29M | -22.95M | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M | -9.13M | -15.99M | -6.49M | -8.33M |
| Depreciation & Amortization | 631K | 563K | 584K | 559K | 491K | 563K | 340K | 326K | 335K | 325K | 426K | 457K |
| Stock-Based Compensation | 0 | 721K | 0 | 504K | 487K | 549K | 354K | 202K | 464K | 611K | 608K | 834K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.9M | 0 |
| Other Non-Cash Items | -5.28M | 13.54M | 5.28M | 2.88M | 879K | 28.2M | 7.09M | -797K | 3.48M | 11M | 1.18M | 1.82M |
| Working Capital Changes | 1.3M | 2.59M | 484K | -478K | -1.04M | -1.16M | 160K | -1.18M | 1.02M | -510K | 113K | -1.61M |
| Change in Receivables | 971K | -870K | 254K | 3.03M | -1.93M | -1.4M | -124K | 76K | 323K | -21K | -166K | 185K |
| Change in Inventory | 64K | 25K | 222K | -234K | -49K | -178K | -232K | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -105K | 3.56M | 0 | -3.11M | 1.03M | 704K | 649K | -1.24M | 854K | -564K | 126K | -1.66M |
| Cash from Investing | -613K | -1.48M | -1.05M | -349K | -307K | -210K | -87K | -191K | -24K | 241K | -1.3M | 123K |
| Capital Expenditures | -613K | -1.48M | -1.05M | -349K | -307K | -214K | 215K | -191K | -24K | -264K | -17K | 123K |
| CapEx % of Revenue | 1915.63% | 129.85% | 403.85% | 67.37% | 14.36% | 14.4% | 186.96% | 183.65% | 13.64% | 84.08% | 3.96% | 26.57% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 231K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 4K | -302K | 0 | 0 | 505K | -1.51M | 0 |
| Cash from Financing | 24.7M | -252K | -120K | -114K | 28.56M | 10.84M | -255K | 9.85M | 0 | -30K | -30K | 12.27M |
| Debt Issued (Net) | -143K | -178K | -120K | -114K | -98K | -82K | -86K | -33K | 0 | -30K | -30K | -29K |
| Equity Issued (Net) | 24.84M | 0 | 0 | 0 | 29.14M | 11.99M | 18K | 15.81M | 0 | 0 | 0 | 13.85M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -74K | 0 | 0 | -487K | -1.07M | -187K | -5.93M | 0 | 0 | 0 | -1.54M |
| Net Change in Cash | 16.62M | -7.11M | -5.78M | -6.74M | 22.39M | 5.27M | -5.89M | 3.68M | -3.85M | -4.35M | -3.58M | 5.57M |
| Free Cash Flow | -8.25M | -7.02M | -5.55M | -6.63M | -6.17M | -5.57M | -5.34M | -6.17M | -3.85M | -4.83M | -2.28M | -6.83M |
| FCF Margin % | -25787.5% | -616.68% | -2135.38% | -1279.54% | -288.35% | -374.7% | -4640% | -5931.73% | -2189.77% | -1536.94% | -530.54% | -1475.59% |
| FCF Growth % | -33.85% | -26.15% | -4.05% | -7.44% | -59.96% | -15.38% | -134.45% | 9.7% | 53.57% | 53.82% | 81.43% | 44.75% |
| FCF per Share | -0.24 | -0.23 | -0.17 | -0.21 | -0.24 | -0.32 | -0.39 | -0.48 | -0.47 | -0.58 | -0.28 | -0.84 |
| FCF Conversion (FCF/Net Income) | 1.78x | 0.24x | 0.41x | 0.64x | 0.88x | 0.16x | 0.41x | 1.32x | 0.42x | 0.29x | 0.35x | 0.82x |
| Interest Paid | 0 | 0 | 24K | 0 | 0 | 25K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |